EMEA-002746-PIP01-20-M03 - paediatric investigation plan

Seltorexant
PIPHuman

Key facts

Active Substance
Seltorexant
Therapeutic area
Psychiatric disorders
Decision number
P/0104/2024
PIP number
EMEA-002746-PIP01-20-M03
Pharmaceutical form(s)
  • Film-coated tablet
  • Age-appropriate dosage form
Condition(s) / indication(s)
Treatment of major depressive disorder
Route(s) of administration
Oral use
Contact for public enquiries

Janssen-Cilag International NV

E-mail: contact@janssen-emea.com
Tel: +40 744383413

Decision type
PM: decision on the application for modification of an agreed PIP
Decision date

Decision

Share this page